Technology

Evoke Pharma

$2.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-1.73%) Today
+$0.01 (+0.35%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Evoke Pharma and other stocks, options, and ETFs commission-free!

About EVOK

Evoke Pharma, Inc. Common Stock, also called Evoke Pharma, is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA. The listed name for EVOK is Evoke Pharma, Inc. Common Stock.

CEO
David A. Gonyer
Employees
5
Headquarters
Solana Beach, California
Founded
2007
Market Cap
88.22M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
844.14K
High Today
$2.93
Low Today
$2.80
Open Price
$2.93
Volume
307.09K
52 Week High
$6.06
52 Week Low
$0.79

Collections

EVOK Earnings

-$0.28
-$0.19
-$0.09
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, Pre-Market

You May Also Like

YAHOY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure